Histiocytosis X Langerhans Cells React with Antiinterleukin-2 Receptor Monoclonal Antibody

References

• Lichtenstein L. Histiocytosis X (eosinophilic granuloma of bone, Letterer-Siwe disease and Schüller-Christian disease). Further observations of pathological and clinical importance. J Bone Joint Surg 1964; 46A: 76–90
   Google Scholar
• Basset F, Turiaf J. Identification par la microscopie électronique de particules de nature probablement virale dans les lésions granulomateuses d'une histiocytose “X”. Pulmonaire 1965; 261: 3701–3
   Google Scholar
• Basset F, Nezelof C, Turiaf J. Présence en microscopie électronique de structures filamenteuses originales dans les lésions pulmonaires et osseuses de l'histiocytose X. Etat actuel de la question. Bull Soc Med Hop (Paris) 1966; 117: 413–26
   Google Scholar
• Birbeck M S, Breathnach A S, Everall J D. An electron microscopic study of basal melanocyte and high level clear cells (Langerhans cell) in vitiligo. J Invest Derm 1961; 37: 51–64
   Web of Science ®Google Scholar
• Nezelof C, Basset F, Rousseau M F. Histiocytosis X: Histogenetic arguments for a Langerhans cell origin. Biomedicine 1973; 18: 365–71
   PubMedGoogle Scholar
• Nezelof C, Barbey S. Histiocytosis: Nosology and pathobiology. Pediatr Pathol 1985; 3: 1–41
   PubMedGoogle Scholar
• Ree H J, Kadin M E. Peanut agglutinin. A useful marker for histiocytosis X and interdigitating reticulum cells. Cancer 1986; 57: 282–7
   PubMed Web of Science ®Google Scholar
• Barbey S, Jaubert F, Nogues C, Gane P, Nezelof C. Histiocytosis X. Reactivity of X bodies with concanavalin A, peanut agglutinin and BSPT pleads for their plasma membrane origin. Path Res Pract, (in press)
   Google Scholar
• Fithian E, Kung P, Goldstein G, Rubenfeld M, Fenoglio C, Edelson R. Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 2541–4
   PubMed Web of Science ®Google Scholar
• Rousseau-Merck M F, Barbey S, Jaubert F, Bach M A, Chatenoud L, Nezelof C. Reactivity of histiocytosis X cells with monoclonal antibodies. Pathol Res Pract 1983; 177: 8–12
   Google Scholar
• Murphy G, Bhan A K, Sato S, Mihm M C, Jr., Harrist T J. A new immunologic marker for human Langerhans cells. N Engl J Med 1981; 304: 791–2
   PubMed Web of Science ®Google Scholar
• Murphy G F, Harrist T J, Bhan A K, Mihm M C, Jr. Distribution of cell surface antigens in histiocytosis X cells. Quantitative immunoelectron microscopy using monoclonal antibodies. Lab Invest 1983; 48: 90–7
   PubMed Web of Science ®Google Scholar
• Nakajima T, Watanabe S, Sato Y, Shimosato Y, Motoi M, Lennert K. S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gann 1982; 73: 429–32
   PubMedGoogle Scholar
• Takahashi K, Isobe T, Ohtsuki Y, Sonobe H, Takeda I, Akagi T. Immunohistochemical localization and distribution of S-100 proteins in the human lymphoreticular system. Am J Pathol 1984; 116: 497–503
   PubMed Web of Science ®Google Scholar
• Ide F, Iwase T, Saito I, Umemura S, Nakajima T. Immunohistochemical and ultrastructural analysis of the proliferating cells in histiocytosis X. Cancer 1984; 53: 917–21
   PubMed Web of Science ®Google Scholar
• Chu T, D'Angio G J, Favara B E, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet 1987; ii2: 41–2
   Google Scholar
• Hemler M E, Malissen B, Rebai N, et al. A 55,000 M surface antigen on activated human T lymphocytes defined by a monoclonal antibody. Hum Immunol 1983; 8: 153–65
   Google Scholar
• Hemler M E, Brenner M B, McLean J M, Strominger J L. Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells. Proc Natl Acad Sci USA 1984; 81: 2172–5
   PubMedGoogle Scholar
• Leonard W J, Depper J M, Uchiyama T, Smith A K, Waldmann T A, Greene W C. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor: Partial characterization of the receptor. Nature 1982; 300: 267–9
   PubMed Web of Science ®Google Scholar
• Robb R J, Greene W C. Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen. J Exp Med 1983; 158: 1332–7
   PubMed Web of Science ®Google Scholar
• Tsudo M, Uchiyama T, Uchino H. Expression of Tac antigen on activated normal human B cells. J Exp Med 1984; 160: 612–7
   PubMed Web of Science ®Google Scholar
• Zubler R H, Lowenthal J W, Erard F, Hashimoto N, Devos R, Macdonald H R. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med 1984; 160: 1170–83
   PubMed Web of Science ®Google Scholar
• Waldmann T A, Goldman C K, Robb R J, et al. Expression of interleukin 2 receptors on activated human B cells. J Exp Med 1984; 160: 1450–66
   PubMed Web of Science ®Google Scholar
• Muraguchi A, Kehrl J H, Longo D L, Volkman D J, Smith K A, Fauci A S. Interleukin 2 receptors on human B cells. Implications for the interleukin 2 in human B cell function. J Exp Med 1985; 161: 181–97
   PubMed Web of Science ®Google Scholar
• Lantz O, Grillot-Courvalin C, Schmitt C, Fermand J P, Brouet J C. Interleukin 2-induced proliferation of leukemic human B cells. J Exp Med 1985; 161: 1225–30
   PubMed Web of Science ®Google Scholar
• Hermann F, Cannistra S A, Levine H, Griffin J D. Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med 1985; 162: 1111–6
   PubMed Web of Science ®Google Scholar
• Steiner G, Tschachler E, Tani M, et al. Interleukin 2 receptors on cultured murine epidermal Langerhans cells. J Immunol 1986; 137: 155–9
   PubMed Web of Science ®Google Scholar
• Arenzana-Seisdedos F, Barbey S, Virelizier J L, Kornprobst M, Nezelof C. Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin I and prostaglandin E2 in culture. J Clin Invest 1986; 77: 326–9
   PubMed Web of Science ®Google Scholar